Latest filing published 18 May 2006 for ACCENTIA BIOPHARMACEUTICALS INC.
Insider track record
No signal scores available.
Timothy D. Ryll: trading record in brief
All filings by Timothy D. Ryll on record concern Accentia Biopharmaceuticals Inc. Over a trading history stretching from 3 April 2006 to 15 May 2006, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 23 June 2006: a transaction of €35k, in Accentia Biopharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy D. Ryll
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 412,892 shares0Common StockSEC:0001181431-06-031355:0
1 of 1 declaration